2nd Annual NASH Summit 2018
As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.
Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:
. Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response
. Evaluating the scientific rationale behind combination therapy for more effective treatment
. Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic
Join 150 drug developers from 120 organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success.